HLscience Co. Ltd Capital Reinvestment Ratio

Latest as of September 2022: 7.14x

HLscience Co. Ltd capital reinvestment ratio. HLscience Co. Ltd (239610) has a Capital Reinvestment Ratio of 7.14x as of September 2022, meaning it reinvests 7% of its operating cash flow (₩420.13 Million) in capital expenditures (₩3.00 Billion). Check HLscience Co. Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

7.14x
Capex / Operating Cash Flow

Operating Cash Flow

₩420.13 Million
KRW

Capital Expenditures

₩3.00 Billion
KRW

Data as of

Sep 2022
Most recent filing

Capital Reinvestment Ratio of HLscience Co. Ltd (2014–2022)

Capital reinvestment ratio of HLscience Co. Ltd from 2014 to 2022. This chart tracks HLscience Co. Ltd's Capital Reinvestment Ratio across 9 annual periods. Also explore 239610 shareholders equity momentum to track the company's year-over-year net asset growth rate.

HLscience Co. Ltd Capital Reinvestment Ratio by Year (2014–2022)

HLscience Co. Ltd capital reinvestment ratio by year from 2014 to 2022. For the full cash flow conversion analysis, see how efficiently does HLscience Co. Ltd generate cash.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2022 2.87x ₩3.95 Billion ₩11.34 Billion ▲ +66.0%
2021 1.73x ₩10.56 Billion ₩18.25 Billion ▲ +1768.5%
2020 0.09x ₩14.97 Billion ₩1.38 Billion ▼ -73.7%
2019 0.35x ₩21.38 Billion ₩7.51 Billion ▲ +810.0%
2018 0.04x ₩13.02 Billion ₩502.80 Million ▼ -95.5%
2017 0.85x ₩5.83 Billion ₩4.99 Billion ▲ +10.8%
2016 0.77x ₩5.53 Billion ₩4.27 Billion ▲ +246.4%
2015 0.22x ₩3.10 Billion ₩691.75 Million ▲ +36.2%
2014 0.16x ₩2.31 Billion ₩378.21 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow